Clinical Trial Update: Depression Study In Elderly Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an antidepressant for major depressive disorder in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major, Major Depressive Disorder (MDD) | Phase 3 | Status: COMPLETED